SKI 2670Alternative Names: SKI2670
Latest Information Update: 08 Apr 2016
At a glance
- Originator SK Chemicals
- Mechanism of Action Gonadotropin releasing hormone inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Uterine diseases
Most Recent Events
- 08 Apr 2016 Phase-I development is ongoing in South Korea
- 01 Jul 2014 Phase-I clinical trials in Uterine disorders (in volunteers) in South Korea (PO)